Compare Wayfair Inc (W) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wayfair Inc vs Zoetis Inc — how do they compare? Wayfair Inc trades at $105.74 (market cap $14.40B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.1× Wayfair Inc's market cap, and Zoetis Inc pays a 2.9% dividend while Wayfair Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Wayfair Inc for 8 Days and Zoetis Inc for 70 Days on average.
| W | ZTS | |
|---|---|---|
Market Cap | $14.40B | $30.20B |
Volume | 2,102,856 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $119.05 | $147.53 |
52-Week Low | $57.40 | $69.09 |
Typical Hold Time | 8 Days | 70 Days |
Enterprise Value | $16.73B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Wayfair (W) trades at $105.13, up 0.63% with bullish technical signals and strong analyst support. The stock shows positive momentum with recent earnings beats and a consensus price target of $114.13. While revenue growth remains steady at $12.9B for 2026, the company continues to operate at a net loss margin of -2.49%, though operating cash flow improved to $665M. Recent developments include store expansion and new brand campaigns positioning for future growth.
Wayfair presents a growth opportunity with bullish technicals and analyst consensus, but faces fundamental challenges with persistent losses and high debt-to-asset ratio of 95.11%. The stock's upside potential depends on margin improvement and successful execution of retail expansion, while downside risks include competitive pressures and macroeconomic headwinds affecting consumer spending.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
